PMOS is a common condition affecting an estimated one in eight women of reproductive age worldwide and 4.5 million Filipino women, according to information from Zuellig Pharma. Its former name often led many people to understand it as merely an ovarian cyst condition, even though some women with PCOS may not have ovarian cysts at all.
The key point of the new name is to encourage women to view this condition more holistically, particularly insulin resistance, which may increase the risk of obesity, prediabetes, type 2 diabetes and other non-communicable diseases, or NCDs, such as cardiovascular disease.
This is especially true for obesity, with more than half (52.06 percent) of Filipino women in a recent PCOS research classified as obese, reporting weight gain (66.15 percent) as a major symptom.
PMOS is, therefore, not a “new disease,” but a name that helps describe the condition more in line with reality. Possible symptoms include irregular menstrual periods, acne, excessive hair growth, thinning hair easy weight gain, infertility, or, in some cases, no obvious symptoms in the early stage.
Every woman should therefore be aware that obesity and diabetes may be closer than they think. The risk can begin as early as adolescence, reproductive age, or working age, even while living a normal daily life without realizing it.